The pharmaceutical industry has long grappled with a massive disconnect between the rapid pace of computational drug discovery and the often-stagnant timelines of physical manufacturing and distribution. In a move designed to bridge this gap, Insilico Medicine and Bora Pharmaceuticals have entered
The landscape of neurological research underwent a fundamental transformation with the publication of the 2024 McDonald Criteria in The Lancet Neurology, setting a new benchmark for diagnostic accuracy and speed. These updated standards replaced the long-standing 2017 framework, introducing a more
The global healthcare sector is currently wrestling with the monumental challenge of shifting from a volume-based productivity model to one rooted in the actual health outcomes achieved for every dollar spent. This transition, widely known as value-based healthcare, has long remained an
The staggering acceleration of chronic metabolic conditions globally has forced a fundamental transformation in how medical researchers conceptualize, design, and execute the large-scale clinical investigations necessary for drug approval. For decades, the pharmaceutical industry relied on a rigid,
Stroke remains one of the most devastating health events for aging populations because its onset often follows a period of silent physiological decline that bypasses standard detection methods. Traditional medical models rely heavily on periodic clinical visits, which capture only a momentary
The diagnosis of an aggressive glioblastoma in one of the world's leading pathological experts created an unprecedented opportunity to challenge established medical boundaries through self-experimentation. Professor Richard Scolyer, recognized globally for his pioneering work in melanoma, turned
